BURRIS ET AL: "Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil" EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 33, 1 January 1997 (1997-01-01), pages S18-S22, XP005058654 ISSN: 0959-8049 (B1)

FAN ZHAO ET AL: "Gemcitabine and oxaliplatin combination chemotherapy in 30 patients with advanced pancreatic carcinoma" THE CHINESE-GERMAN JOURNAL OF CLINICAL ONCOLOGY, SPRINGER-VERLAG, BE, vol. 6, no. 5, 1 October 2007 (2007-10-01), pages 461-463, XP019546858 ISSN: 1613-9089 (B1)

FR-A- 2 873 925 (B1)

MILLAN C G ET AL: "Drug, enzyme and peptide delivery using erythrocytes as carriers" JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 95, no. 1, 20 February 2004 (2004-02-20), pages 27-49, XP004487812 ISSN: 0168-3659 (B1)

LESSNER H E ET AL: "PHASE 2 STUDY OF L ASPARAGINASE IN THE TREATMENT OF PANCREATIC CARCINOMA" CANCER TREATMENT REPORTS, vol. 64, no. 12, 1980, pages 1359-1361, XP009099700 ISSN: 0361-5960 (B1)

LESSNER H E ET AL: "TREATMENT OF PANCREATIC CARCINOMA WITH L ASPARAGINASE" DIGESTION, vol. 16, no. 3, 1977, page 255, XP009099698 ISSN: 0012-2823 (B1)

KRAVTZOFF R ET AL: "ERYTHROCYTES AS CARRIERS FOR L-ASPARAGINASE. METHODOLOGICAL AND MOUSE IN-VIVO STUDIES" JOURNAL OF PHARMACY AND PHARMACOLOGY, LONDON, GB, vol. 42, no. 7, 1 July 1990 (1990-07-01), pages 473-476, XP009045649 ISSN: 0022-3573 (B1)